Article
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Breast cancer research : BCR - 7 Aug 2018
Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céline
Abstract excerpt
BACKGROUND: Inflammatory breast cancer (IBC) is the most aggressive form of primary breast cancer. Using a custom-made breast cancer gene sequencing panel, we investigated somatic mutations in IBC to better understand the genomic differences compared with non-IBC and to consider new targeted therapy in IBC patients. METHODS: Targeted next-generation sequencing (NGS) of 91 candidate breast cancer-associated genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.